Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Sanford-Burnham Seeks Improved Pharma Ties with New CEO from GSK

August 19, 2014 – 5:02 pm | Edit Post
Sanford-Burnham Seeks Improved Pharma Ties with New CEO from GSK

Following an executive search that took about 18 months, San Diego’s Sanford-Burnham Medical Research Institute named a new CEO today. He is Perry Nisen, a pediatric cancer specialist who specialized…

[[Click headline to continue reading.]]

SDSU ‘sequences the sea’

August 19, 2014 – 4:38 pm | Edit Post

Scientists make first effort to decode microbes DNA in open ocean.

SDSU sequences the sea

August 19, 2014 – 4:38 pm | Edit Post

Scientists make first effort to decode microbes DNA in open ocean.

In search of a ‘virtual cure’ for diabetes

August 19, 2014 – 11:04 am | Edit Post

The FDA has given permission to try the therapy on Type 1 diabetics.

Sanford-Burnham announces next CEO

August 19, 2014 – 10:01 am | Edit Post

Sanford-Burnham’s Board of Trustees today announced that it has appointed Perry Nisen, M.D., Ph.D., as chief executive officer. Dr. Nisen joins Sanford-Burnham from pharmaceutical company GlaxoSmithKline.

Sanford-Burnham announces next CEO

August 19, 2014 – 10:01 am | Edit Post

Sanford-Burnham’s Board of Trustees today announced that it has appointed Perry Nisen, M.D., Ph.D., as chief executive officer. Dr. Nisen joins Sanford-Burnham from pharmaceutical company GlaxoSmithKline.

Sanford-Burnham announces next CEO

August 19, 2014 – 10:01 am | Edit Post

Sanford-Burnham’s Board of Trustees today announced that it has appointed Perry Nisen, M.D., Ph.D., as chief executive officer. Dr. Nisen joins Sanford-Burnham from pharmaceutical company GlaxoSmithKline.

Meet new Sanford-Burnham CEO Perry Nisen

August 19, 2014 – 10:00 am | Edit Post

Perry Nisen to bring drug development, science skills to La Jolla.

Meet Sanford-Burnham’s new CEO Perry Nisen

August 19, 2014 – 10:00 am | Edit Post

Perry Nisen to bring marketing, science skills to La Jolla.

HealthQuest Capital Raises $110M for Debut Fund with Medtech Focus

August 19, 2014 – 3:00 am | Edit Post
HealthQuest Capital Raises $110M for Debut Fund with Medtech Focus

HealthQuest Capital, founded last year by Sofinnova Ventures partner Garheng Kong, says it has raised $110 million for its debut fund and already has invested in several medical technology and…

[[Click headline to continue reading.]]